0001493152-22-009627.txt : 20220411 0001493152-22-009627.hdr.sgml : 20220411 20220411180521 ACCESSION NUMBER: 0001493152-22-009627 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220310 FILED AS OF DATE: 20220411 DATE AS OF CHANGE: 20220411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Barr Jason Michael CENTRAL INDEX KEY: 0001645550 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 22820699 MAIL ADDRESS: STREET 1: 902 BROADWAY, 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 BUSINESS PHONE: (215) 345-0919 MAIL ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4/A 1 ownership.xml X0306 4/A 2022-03-10 2022-03-16 0 0000868278 ProPhase Labs, Inc. PRPH 0001645550 Barr Jason Michael 711 STEWART AVENUE, SUITE 200 GARDEN CITY, NY 11530 1 0 0 0 Common Stock, par value $0.0005 2022-03-10 2022-03-15 4 P 0 721 6.48 A 30962 D The transaction reported herein was a purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program. The original Form 4 filed on March 16, 2022 mistakenly reported that the Reporting Person acquired 750 shares pursuant to an automatic broker-administered dividend reinvestment program. /s/ Jason Barr 2022-04-11